Zomedica Corp [AMEX: ZOM] traded at a high on Monday, posting a 11.57 gain after which it closed the day’ session at $0.16.
The results of the trading session contributed to over 14806029 shares changing hands. Over the past one week, the price volatility of Zomedica Corp stands at 7.83% while the volatility over the past one month is 4.88%.
The market cap for ZOM stock reached $158.75 million, with 979.95 million shares outstanding and 964.36 million shares in the current float. Compared to the average trading volume of 4.94M shares, ZOM reached a trading volume of 14806029 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Zomedica Corp [ZOM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZOM shares is $0.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZOM stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Dawson James have made an estimate for Zomedica Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 06, 2023.
The Average True Range (ATR) for Zomedica Corp is set at 0.01, with the Price to Sales ratio for ZOM stock in the period of the last 12 months amounting to 6.30. The Price to Book ratio for the last quarter was 0.66, with the Price to Cash per share for the same quarter was set at 0.09.
How has ZOM stock performed recently?
Zomedica Corp [ZOM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.13. With this latest performance, ZOM shares gained by 15.47% in over the last four-week period, additionally sinking by -8.73% over the last 6 months – not to mention a drop of -19.32% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZOM stock in for the last two-week period is set at 72.72, with the RSI for the last a single of trading hit 82.46, and the three-weeks RSI is set at 65.63 for Zomedica Corp [ZOM]. The present Moving Average for the last 50 days of trading for this stock 0.1371, while it was recorded at 0.1466 for the last single week of trading, and 0.1632 for the last 200 days.
Zomedica Corp [ZOM]: Deeper insight into the fundamentals
Zomedica Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.49 and a Current Ratio set at 11.06.
Insider trade positions for Zomedica Corp [ZOM]
The top three institutional holders of ZOM stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in ZOM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in ZOM stock with ownership which is approximately 5.8386%.
